Sentences with phrase «measure of risk by»

Not exact matches

From our definition there flows an important corollary: The riskiness of an investment is not measured by beta (a Wall Street term encompassing volatility and often used in measuring risk) but rather by the probability — the reasoned probability — of that investment causing its owner a loss of purchasing power over his contemplated holding period.

That information — augmented by advocacy efforts from such Addyi supporters as the National Organization for Women and National Consumers League — turned the tide, and the FDA's joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee voted 18 to 6 to support approval for HSDD treatment, contingent on Sprout consenting to risk - mitigation measures like warnings and restrictions to prevent misuse.

We then ranked the remaining names by a simple measure of the market's perceived bankruptcy risk - Market Cap (MC) divided by Enterprise Value (EV).

«It is a terrible mistake for investors with long - term horizons... to measure their investment «risk» by their portfolio's ratio of bonds to stocks,» Buffett wrote in the February 24 letter.

«Although we expect that the Greek government will implement the required measures, the risk of early elections is increasing given the rising political cost to the government and its slim majority in the parliament... Early elections might bring a new and more reform - minded conservative government, but Greece's economy would be hit again by prolonged uncertainty, after having just started to record positive growth,» Moody's said.

Beyond then, we expect the company to sustain credit measures that are consistent with its intermediate financial risk profile, characterized by fully adjusted debt to EBITDA of 2.5x - 3.0 x, funds from operations to debt of more than 25 %, and EBITDA interest coverage of more than 5.0 x.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

This might mean, for example, that the central bank would need to run a more stimulative policy than it would have otherwise to offset the effect of macroprudential policies, and the macroprudential authority would impose more stringent measures than it would have otherwise to counteract the leverage and risk taking generated by looser monetary policy.

It represents the difference between a fund's actual returns and its expected performance, given its level of risk as measured by beta (see definition of Beta).

ATLANTA — Visa and MasterCard are using security measures prone to fraud, putting retailers and customers at risk of hacking attacks by cyber thieves, The Home Depot Inc. says in a new federal lawsuit.

As always, the strongest prospective market return / risk profile is associated with a material retreat in valuations followed by an early improvement in broad measures of market internals.

Similarly, even though the expected return to stocks is negative in the current climate, the risk (measured by the variability of possible outcomes) is also very wide.

A shift in investor risk - preferences, as revealed by a subtle (and eventually profound) deterioration of observable market internals and risk measures.

This mistake represents a) precisely the amnesia about reckless finance that repeatedly shows up years after the last crisis, b) an underestimate by the Senate Democrats signing on to the measure of the risk brought back into the system, and c) an almost completely unnecessary bit of work.

The annualized percentage difference between a fund's actual returns and its expected performance given its level of market risk, as measured by beta.

With the S&P 500 within about 8 % of its highest level in history, with historically reliable valuation measures at obscene levels, implying near - zero 10 - 12 year S&P 500 nominal total returns; with an extended period of extreme overvalued, overbought, overbullish conditions replaced by deterioration in market internals that signal a clear shift toward risk - aversion among investors; with credit spreads on low - grade debt blowing out to multi-year highs; and with leading economic measures deteriorating rapidly, we continue to classify market conditions within the most hostile return / risk profile we identify — a classification that has been observed in only about 9 % of history.

That still leaves one - fifth of the systemic risk score accounted for by other measures, but perhaps the answer is not quite so simple.

Historically - reliable valuation measures are remarkably useful in projecting long - term and full - cycle market outcomes, but the behavior of the market over shorter segments of the market cycle is driven by the psychological inclination of investors toward speculation or risk - aversion.

The Market Climate remains on a Crash Warning, characterized by extremely unfavorable valuations, unfavorable trend uniformity, and hostile yield trends, particularly long - term bond yields and various measures of risk premiums.

If that were to happen, we would need S&P strength to be confirmed by other action, particularly other measures of risk - premiums.

Is risk measured by the fact that people are quitting their day jobs and taking the leap of entrepreneurship — too much generalisation.

Generally, you calculate the hurdle rate by adding together the risk - free interest rate, a measure of inflation expectations over the life of the project and a premium to compensate for the investment's risk.

Returns by media type are similar whether measured simply in excess of the risk - free rate or adjusted for multiple risk factors common to long / short U.S. equity hedge funds.

In the March 2009 version of their paper entitled «Higher Risk, Lower Returns: What Hedge Fund Investors Really Earn», Ilia Dichev and Gwen Yu measure actual hedge fund investor returns by integrating the returns of the funds they hold with the timing and magnitude of their capital flows into and out of these funds.

Sentiment in the options market, as indicated by 1 - month risk reversals (a measure derived from the relative prices of put and call options in the Australian dollar), has also become more bullish since mid 2004.

Measured across all loan products, and taking into account changes in customer risk margins, however, it seems that interest rates paid on average by small businesses have increased by a little less than the rise in interest rates directly due to the tightening of monetary policy.

Alpha is a measure of the difference between a portfolio's actual returns and its expected performance, given its level of risk as measured by beta.

As usual, I don't place too much emphasis on this sort of forecast, but to the extent that I make any comments at all about the outlook for 2006, the bottom line is this: 1) we can't rule out modest potential for stock appreciation, which would require the maintenance or expansion of already high price / peak earnings multiples; 2) we also should recognize an uncomfortably large potential for market losses, particularly given that the current bull market has now outlived the median and average bull, yet at higher valuations than most bulls have achieved, a flat yield curve with rising interest rate pressures, an extended period of internal divergence as measured by breadth and other market action, and complacency at best and excessive bullishness at worst, as measured by various sentiment indicators; 3) there is a moderate but still not compelling risk of an oncoming recession, which would become more of a factor if we observe a substantial widening of credit spreads and weakness in the ISM Purchasing Managers Index in the months ahead, and; 4) there remains substantial potential for U.S. dollar weakness coupled with «unexpectedly» persistent inflation pressures, particularly if we do observe economic weakness.

One of the victims of this risk - off move has been Japanese equities, which, as measured by the TOPIX, is roughly flat for the year to date through May 1 (in local currency).

Sharpe Ratio The Sharpe ratio, developed by Nobel Prize winner William Sharpe, provides a measure of a fund's historical risk - adjusted performance.

Alpha The difference between a fund's actual returns versus its expected performance, given its level of market risk as measured by beta.

The risk exposure to which you exposed your capital, measured not by volatility in market quotation but in the price paid relative to intrinsic value with an adjustment for the potential of wipeout, is the real secret of building wealth over the long term.

Historically, the most reliable way to measure risk attitudes is by the uniformity or divergence of price movements across a wide range of securities.

Alpha: Measures the difference between a portfolio's actual returns and its expected performance, given its level of risk as measured by Beta.

By most measures, my portfolio would be considered a lower risk and conservative collection of stocks.

A study by the non-profit group European Network on Debt and Development (Eurodad), says that despite recent revelations over corporate tax dodging, the EU still provides a «wide - range» of options for firms seeking tax loopholes and is failing to enforce transparency measures that would cut money laundering risks.

The combination of the above risk management measures driven by the investor's specific goals and objectives may provide the investor with a greater sense of control over their own destiny.

However, the risk of being thrown off the scent can be reduced by having an objective way of measuring the ebbs and flows in the confidence that drives, among other things, the performance of the gold market.

Comparable measures of credit risk derived from credit default swaps have declined by even more (see «New Measures of Credit Risk», Reserve Bank Bulletin, July 2003, for a discussion of these memeasures of credit risk derived from credit default swaps have declined by even more (see «New Measures of Credit Risk», Reserve Bank Bulletin, July 2003, for a discussion of these measurrisk derived from credit default swaps have declined by even more (see «New Measures of Credit Risk», Reserve Bank Bulletin, July 2003, for a discussion of these meMeasures of Credit Risk», Reserve Bank Bulletin, July 2003, for a discussion of these measurRisk», Reserve Bank Bulletin, July 2003, for a discussion of these measuresmeasures).

It is a terrible mistake for investors with long - term horizons — among them, pension funds, college endowments and savings - minded individuals — to measure their investment «risk» by their portfolio's ratio of bonds to stocks.

Risk is measured by calculating the average of relative volatility, relative Value at Risk (VaR), relative Estimated Tail Loss (ETL) and relative stressed downside capture.

«The riskiness of an investment is not measured by beta (a Wall Street term encompassing volatility and often used in measuring risk) but rather by the probability — the reasoned probability — of that investment causing its owner a loss of purchasing - power over his contemplated holding period.»

I suspect fear mongering to justify disproportionate retribution and agendas by those who don't have to risk life and limb but profit from war and politicians being puppets of that with measure to deceive the public to keep the public in line with their policy about war.

A WWEMP is a comprehensive undertaking that considers all site specific conditions and reduces the risk of effluent plant failure in the long run by establishing water management measures from factory floor to end - of - pipe treatment and beyond.

Known as NDtech, the state - of - the - art system further strengthens Amorim's quality control measures by screening individual cork stoppers on the production line to eliminate the risk of any natural whole cork contaminated with releasable TCA reaching winemakers.

Known as NDtech, the cutting - edge technology greatly enhances Amorim's quality control measures by screening individual cork stoppers on the production line to eliminate the risk of corks contaminated with 2,4,6 - trichloroanisole (TCA) reaching winemakers.

Because these risk factors are so broad, doctors test every pregnant woman for signs of preeclampsia by measuring blood pressure and checking the urine for protein, usually at every prenatal appointment.

The 1998 and 2005 AAP policy statements and the Back to Sleep campaign not only addressed the importance of back sleeping but also provided recommendations for other infant care practices that may reduce the risk of SIDS and other sleep - related infant deaths.1, 9 Unfortunately, the ability to measure the prevalence of these other risk factors is limited by lack of data.

By not having indicated that you bedshared and your baby lived and thrived it artificially elevates the statistical calculations measuring the relative risks of bedsharing compared with crib sleeping.

You can help minimize colicky behavior by taking preventive measures to reduce your baby's risk of illness.